PortfoliosLab logoPortfoliosLab logo
ZIVO vs. BYRN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ZIVO vs. BYRN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ZIVO Bioscience, Inc. (ZIVO) and Byrna Technologies Inc. (BYRN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ZIVO achieves a -54.02% return, which is significantly higher than BYRN's -72.90% return. Over the past 10 years, ZIVO has outperformed BYRN with an annualized return of 28.41%, while BYRN has yielded a comparatively lower 6.61% annualized return.


ZIVO

1D
0.00%
1M
-23.81%
6M
-61.90%
YTD
-54.02%
1Y
-59.88%
3Y*
-30.66%
5Y*
-28.23%
10Y*
28.41%
ALL TIME*
11.11%

BYRN

1D
-0.22%
1M
-34.72%
6M
-66.81%
YTD
-72.90%
1Y
-78.66%
3Y*
9.14%
5Y*
-28.29%
10Y*
6.61%
ALL TIME*
3.96%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$4.54M$5.26M$3.58M
$4.68K$3.81K$4.67K

ZIVO vs. BYRN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ZIVO
ZIVO Bioscience, Inc.
-54.02%-59.53%1,691.67%-92.00%-12.89%1,813.33%-11.76%30.77%44.44%-5.26%
BYRN
Byrna Technologies Inc.
-72.90%-41.72%350.86%-18.49%-41.27%-7.93%663.16%26.67%7.14%-30.00%

Correlation

The correlation between ZIVO and BYRN is 0.12, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.12

Correlation (3Y)
Balances recent behavior with more history.

0.05

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.07

Correlation (10Y)
Provides a long-term view across more market conditions.

0.05

Correlation (All Time)
Calculated using the full available price history since Sep 24, 2012

0.03

Fundamentals

Market Cap

ZIVO:

$15.55M

BYRN:

$103.25M

EPS

ZIVO:

-$1.70

BYRN:

-$0.16

PS Ratio

ZIVO:

131.10

BYRN:

0.99

Total Revenue (TTM)

ZIVO:

$119.03K

BYRN:

$108.86M

Gross Profit (TTM)

ZIVO:

$39.21K

BYRN:

$57.17M

EBITDA (TTM)

ZIVO:

-$6.59M

BYRN:

-$3.55M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ZIVO vs. BYRN — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ZIVO
ZIVO Risk / Return Rank: 3333
Overall Rank
ZIVO Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
ZIVO Sortino Ratio Rank: 4747
Sortino Ratio Rank
ZIVO Omega Ratio Rank: 4949
Omega Ratio Rank
ZIVO Calmar Ratio Rank: 1919
Calmar Ratio Rank
ZIVO Martin Ratio Rank: 2020
Martin Ratio Rank

BYRN
BYRN Risk / Return Rank: 55
Overall Rank
BYRN Sharpe Ratio Rank: 55
Sharpe Ratio Rank
BYRN Sortino Ratio Rank: 44
Sortino Ratio Rank
BYRN Omega Ratio Rank: 33
Omega Ratio Rank
BYRN Calmar Ratio Rank: 88
Calmar Ratio Rank
BYRN Martin Ratio Rank: 77
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ZIVO vs. BYRN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ZIVO Bioscience, Inc. (ZIVO) and Byrna Technologies Inc. (BYRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ZIVOBYRNDifference
Sharpe ratioReturn per unit of total volatility

+0.63

Sortino ratioReturn per unit of downside risk

+2.43

Omega ratioGain probability vs. loss probability

1.08

0.75

+0.33

Calmar ratioReturn relative to maximum drawdown

-0.67

-0.90

+0.23

Martin ratioReturn relative to average drawdown

-1.09

-1.44

+0.35

ZIVO vs. BYRN - Sharpe Ratio Comparison

The current ZIVO Sharpe Ratio is -0.34, which is higher than the BYRN Sharpe Ratio of -0.97. The chart below compares the historical Sharpe Ratios of ZIVO and BYRN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ZIVO vs. BYRN - Drawdown Comparison

The maximum ZIVO drawdown since its inception was -98.52%, which is greater than BYRN's maximum drawdown of -92.51%. Use the drawdown chart below to compare losses from any high point for ZIVO and BYRN.


Loading charts...

Drawdown Indicators


ZIVOBYRNDifference

Max Drawdown

Largest peak-to-trough decline

-98.52%

-92.51%

-6.01%

Max Drawdown (1Y)

Largest decline over 1 year

-93.85%

-88.49%

-5.36%

Max Drawdown (3Y)

Largest decline over 3 years

-96.18%

-90.70%

-5.48%

Max Drawdown (5Y)

Largest decline over 5 years

-98.52%

-92.51%

-6.01%

Max Drawdown (10Y)

Largest decline over 10 years

-98.52%

-92.51%

-6.01%

Current Drawdown

Current decline from peak

-87.77%

-86.69%

-1.08%

Average Drawdown

Average peak-to-trough decline

-63.98%

-52.64%

-11.34%

Ulcer Index

Depth and duration of drawdowns from previous peaks

57.67%

55.21%

+2.46%

Volatility

ZIVO vs. BYRN - Volatility Comparison

The current volatility for ZIVO Bioscience, Inc. (ZIVO) is 46.24%, while Byrna Technologies Inc. (BYRN) has a volatility of 50.27%. This indicates that ZIVO experiences smaller price fluctuations and is considered to be less risky than BYRN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ZIVOBYRNDifference

Volatility (1M)

Calculated over the trailing 1-month period

46.24%

50.27%

-4.03%

Volatility (6M)

Calculated over the trailing 6-month period

139.92%

77.46%

+62.46%

Volatility (1Y)

Calculated over the trailing 1-year period

185.49%

82.35%

+103.14%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

142.36%

75.62%

+66.74%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

1,082.66%

96.48%

+986.18%

Dividends

ZIVO vs. BYRN - Dividend Comparison

Neither ZIVO nor BYRN has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ZIVO vs. BYRN - Financials Comparison

This section allows you to compare key financial metrics between ZIVO Bioscience, Inc. and Byrna Technologies Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


ZIVO and BYRN have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BYRN has higher volatility (50.27%) compared to ZIVO (46.24%). In terms of maximum drawdown, ZIVO dropped -98.52% vs BYRN's -92.51%.

ZIVO currently has the higher Sharpe Ratio (-0.34 vs -0.97), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ZIVO and BYRN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer